Why the study?
Chemotherapy-induced cardiotoxicity is a concern in patients with gynecologic cancer, prompting assessment of left ventricular myocardial deformation and its link to chemotherapy factors.
Does chemotherapy exposure reduce LV myocardial deformation in patients with gynecologic cancer compared to healthy controls?
Does chemotherapy exposure reduce LV myocardial deformation in patients with gynecologic cancer compared to healthy controls?
CMR tissue tracking reveals subclinical left ventricular myocardial dysfunction, indicated by impaired global strain, in patients with gynecologic cancer undergoing chemotherapy even when LVEF is preserved.
Answers are grounded in this paper and cite their sources.
Strain imaging may identify subclinical LV dysfunction missed by LVEF in gynecologic cancer chemotherapy; leaves open need for outcome trials before routine use.
Background Chemotherapy-induced cardiotoxicity is a concern for patients with gynecologic cancer. This study aimed to assess left ventricular (LV) myocardial deformation in patients with gynecologic cancer undergoing chemotherapy and to investigate the association between myocardial deformation and chemotherapy factors. Methods Cardiac magnetic resonance (CMR) was performed to assess LV deformation parameters using CMR tissue tracking based on cine images. Serum myocardial injury biomarker were measured. Deformation parameters were compared between healthy controls and patients. Changes in deformation were assessed as chemotherapy progressed. Correlations between LV deformation parameters, clinical characteristics, and serum myocardial injury biomarkers were also analyzed. Results A total of 86 patients with gynecologic cancer and 30 normal controls were included. Among the patients, 41 completed CMR follow-up with a median interval of 6 months. Compared to the controls, patients exhibited lower absolute value of global radial strain (GRS) (37.30 ± 8.94% vs. 44.32 ± 8.44%), global circumferential strain (GCS) (-22.12 ± 3.05% vs. -24.08 ± 2.13%) and global longitudinal strain (GLS) (median -15.72% [IQR-17.13 to -13.58%] vs. -17.51 ± 2.00 %) (all p < 0.05). Patients with preserved LV ejection fraction (LVEF) also showed impaired global strain (all p < 0.05). GRS (39.71 ± 8.09% vs. median 30.56% [IQR 26.52 to 38.15%]; p = 0.001), GCS (-23.45 ± 2.09% vs. median -19.71% [IQR -21.71 to -19.10%]; p < 0.001) and GLS (-16.17 ± 2.42% vs. median -12.12% [IQR -14.10 to -8.53%]; p < 0.001) further decreased as the number of chemotherapy cycles increased during follow-up (all p < 0.05). Multivariate analysis showed that GCS was independently associated with the number of chemotherapy regimens (Standard regression coefficient [β] = 0.397, p < 0.001). Conclusions Myocardial deformation is more sensitive than LVEF in detecting subclinical left ventricular dysfunction in patients with gynecologic cancer undergoing chemotherapy. GCS was associated with the number of chemotherapy regimens.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: